Results 241 to 250 of about 790,552 (265)
Despite universal healthcare in Switzerland, disparities in post‐acute coronary syndrome (ACS) care persist across educational levels. In a cohort of 6040 patients, those with the lowest education had more cardiovascular risk factors and were less likely to attend cardiac rehabilitation or receive cardiology follow‐up.
Maëlle Achard +14 more
wiley +1 more source
Abstract Background Colchicine shows promise in reducing cardiovascular risk, but a recent study raised the question whether this is really the case. We conducted a meta‐analysis of randomized controlled trials (RCTs) to assess its impact on cardiovascular outcomes in secondary prevention.
Sining Xie +4 more
wiley +1 more source
Correction to: Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial. [PDF]
europepmc +1 more source
Abstract Background Type 2 diabetes mellitus (T2DM) and gout are associated with an increased risk of cardiovascular events. Despite the approval for the secondary prevention of cardiovascular diseases by the United States Food and Drug Administration in 2023, evidence regarding the effectiveness of colchicine among T2DM population remains limited ...
Minjeong Jeon +7 more
wiley +1 more source
Sleep Apnea Specific Hypoxic Burden in Children With Down Syndrome and Typically Developing Children
ABSTRACT Hypoxic burden (HB) is a measure incorporating frequency, depth and duration of respiratory event‐related desaturations. While HB is associated with cardiovascular disease in adults with obstructive sleep apnea (OSA), it has not been assessed in typically developing (TD) children with OSA, nor in children with Down syndrome (DS), who have a ...
Lisa M. Walter +8 more
wiley +1 more source

